The mutual exclusion between isocitrate dehydrogenase (IDH) mutations and TET mutations in AML was the first clue hinting at the downstream convergence of these seemingly disparate molecular pathways (28). The gene discussed is IDH1; the disease is acute myeloid leukemia.